SymBio Pharmaceuticals - Licence agreement for IONSYS terminated
The licence agreement between SymBio and The Medicines Company (MDCO) for the exclusive rights to develop the IONSYS (SyB P-1501) pain patch in...
73 Views
SymBio Pharmaceuticals - Licence agreement for IONSYS terminated
The licence agreement between SymBio and The Medicines Company (MDCO) for the exclusive rights to develop the IONSYS (SyB P-1501) pain patch in...
68 Views
SymBio Pharmaceuticals - New formulations extend Treakisym patent life
SymBio has substantially increased the value of its Treakisym franchise through in-licensing novel bendamustine formulations from Eagle...
68 Views
New formulations extend Treakisym patent life
SymBio has substantially increased the value of its Treakisym franchise through in-licencing novel bendamustine formulations from Eagle...
71 Views
Moving ahead on all fronts
During 2017 we expect updates on all three of SymBio’s main assets. We expect Treakisym sales growth via partner Eisai following approvals during...
182 Views